Enhancing HER2 Evaluation: Correlation between APIS Breast Cancer Subtyping Kit and IHC/ISH for Accurate HER2 Quantification

被引：0
|
作者：
Gasior, A. [1 ]
Gorniak, J. [1 ]
Rollinson, S. [1 ]
Gough, L. [1 ]
Wegscheider, A. [2 ]
Niendorf, A. [2 ]
机构：
[1] APIS Assay Technol, Manchester, Lancs, England
[2] MVZ Prof Dr Med A Niendorf Pathol Hamburg West Gm, Hamburg, Germany
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST047
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [31] Correlation between serum HER2 extracellular domain (HER2 ECD) levels and tumour size in early, advanced and metastatic breast cancer with HER2 overexpression
    Makino, H.
    Tengan, H.
    Tatsuda, K.
    Hashidate, H.
    Mio, K.
    Kiguchi, T.
    Yamazaki, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S114 - S115
  • [32] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [33] HER2 Gene Protein Assay Is Useful to Determine HER2 Status of Breast Carcinoma with HER2 IHC and FISH Double Equivocal Results
    Li, Zaibo
    Hou, Yanjun
    Nitta, Hiroaki
    MODERN PATHOLOGY, 2016, 29 : 54A - 54A
  • [34] A Comparison of IHC and FISH Cytogenetic Methods in the Evaluation of HER2 Status in Breast Cancer
    Wesola, Marta
    Jelen, Michal
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 24 (05): : 899 - 903
  • [35] HER2 Gene Protein Assay Is Useful to Determine HER2 Status of Breast Carcinoma with HER2 IHC and FISH Double Equivocal Results
    Li, Zaibo
    Hou, Yanjun
    Nitta, Hiroaki
    LABORATORY INVESTIGATION, 2016, 96 : 54A - 54A
  • [36] Breast HER2 Insitu Hybridization (HER2 ISH): Acceptable and unacceptable staining criteria impacting on interpretation
    Parry, S.
    Miller, K.
    Ibrahim, M.
    VIRCHOWS ARCHIV, 2012, 461 : S258 - S258
  • [37] Current issues in ER and HER2 testing by IHC in breast cancer
    Gown, Allen M.
    MODERN PATHOLOGY, 2008, 21 : S8 - S15
  • [38] HER2 testing in the MOUNTAINEER trial: Analysis of treatment response based on central HER2 assessment using IHC/ISH and NGS
    Strickler, John H.
    Cercek, Andrea
    Ng, Kimmie
    Siena, Salvatore
    Andre, Thierry
    Van Cutsem, Eric
    Wu, Christina
    Paulson, Andrew Scott
    Hubbard, Joleen M.
    Coveler, Andrew L.
    Fountzilas, Christos
    Kardosh, Adel
    Kasi, Pashtoon Murtaza
    Lenz, Heinz-Josef
    Ciombor, Kristen Keon
    Elez, Elena
    Stecher, Michael
    Cronin, Pauline
    Bieda, Mark
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Comparison between HER2 extracellular domain in serum and HER2 overexpression in breast cancer tissue
    Zidan, J.
    Mzalbat, R.
    Svalb, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S142 - S142
  • [40] Comparison between HER2 extracellular domain in serum and HER2 overexpression in breast cancer tissue
    Zidan, J.
    Mzalbat, R.
    Shnaider, J.
    Sharabi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345